Status:

UNKNOWN

Pain Scores and Complications do Not Differ at Three Recovery Position After Liver Biopsy

Lead Sponsor:

Kocaeli University

Conditions:

Pain, Acute

Liver Diseases

Eligibility:

All Genders

18-80 years

Brief Summary

Liver biopsy is still used as the gold standard in the diagnosis of many liver diseases. During the observation after liver biopsy, patients are hospitalized on their right side, which is the biopsy s...

Detailed Description

Liver biopsy is still used as the gold standard in the diagnosis of many liver diseases. The health practice notification (SUT) makes the diagnosis with liver biopsy mandatory for the treatment of chr...

Eligibility Criteria

Inclusion

  • Cronic hepatitis B İnfection
  • Chronic hepatitis C İnfection
  • NASH
  • DILI
  • Acute or chronic liver damage caused unknown aetiology

Exclusion

  • Refuse to give written informed consent

Key Trial Info

Start Date :

January 1 2018

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

March 1 2021

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT04750031

Start Date

January 1 2018

End Date

March 1 2021

Last Update

February 16 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Kocaeli University Medical Faculty Hospital

İzmit, Kocaeli, Turkey (Türkiye), 41001